{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 83634176
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 434969528
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 9911922
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 346974
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 59572236
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 588434836
            },
            {
                "label": "Fixed assets, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 10930312
            },
            {
                "label": "Net unrealized loss on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNi",
                "unit": "usd",
                "value": 3629891
            },
            {
                "label": "Schedule of Equity Method Investments",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3010000
            },
            {
                "label": "Goodwill, gross",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 12463006
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 25881934
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 654863350
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 25974530
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 768261
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:AccruedClinicalTrialExpenseCurrent",
                "unit": "usd",
                "value": 7370869
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 15378
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:ContractWithCustomerLiabilityAffiliatedEntityCurrent",
                "unit": "usd",
                "value": 39000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2395928
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:DeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 4975484
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:DeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 41539450
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 75501
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 17438841
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 32046
            },
            {
                "label": "Grant funding liability from affiliated entity, net of current portion",
                "concept": "ino:DeferredGrantFundingFromAffiliateNoncurrent",
                "unit": "usd",
                "value": 37500
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 64141
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 73257201
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 209333
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 1542261467
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -960598943
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -265708
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 581606149
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 654863350
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -54402131
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 660697
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 136770
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Granted (in shares)",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 9595947
            },
            {
                "label": "Non-cash interest expense",
                "concept": "ino:NonCashInterestIncomeExpense",
                "unit": "usd",
                "value": 31281
            },
            {
                "label": "Loss on short-term investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": -10151
            },
            {
                "label": "Settlement of receivable with shares of common stock from affiliated entity (PLS)",
                "concept": "ino:SettlementOfReceivableWithSharesOfCommonStockFromEquitySecurity",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -830475
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Net unrealized loss on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedLoss",
                "unit": "usd",
                "value": 847958
            },
            {
                "label": "Non-cash lease expense",
                "concept": "ino:OperatingLeaseNonCashLeaseExpense",
                "unit": "usd",
                "value": 278290
            },
            {
                "label": "Unrealized transaction loss on foreign-currency denominated debt",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 176927
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -8648045
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": -156808
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 19214780
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": -106432
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -75514
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 4735352
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:IncreaseDecreaseInAccruedClinicalTrialExpense",
                "unit": "usd",
                "value": -2579476
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": 125292
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -34963
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": -37500
            },
            {
                "label": "Operating lease right-of-use assets and liabilities, net",
                "concept": "ino:IncreaseDecreaseInOperatingLeaseRightOfUseAssetLeaseLiabilityNet",
                "unit": "usd",
                "value": -558140
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingCurrent",
                "unit": "usd",
                "value": -2461326
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": -19500
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 6478
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -52867428
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 275408976
            },
            {
                "label": "Proceeds from sale or maturity of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 504464
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 210824
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -275115336
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 162105030
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 2632996
            },
            {
                "label": "Taxes paid related to net share settlement of equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 3834785
            },
            {
                "label": "Acquisition of non-controlling interest",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 160903241
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -14419
            },
            {
                "label": "Increase (Decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -167093942
            },
            {
                "label": "Amounts accrued for purchases of property and equipment",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 35370
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 544315
            },
            {
                "label": "Amortization Of Operating Lease Right-Of-Use Assets",
                "concept": "ino:AmortizationOfOperatingLeaseRightOfUseAssets",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 371120
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 39044418
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 13881194
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 52925612
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -52554492
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 769237
            },
            {
                "label": "Interest expense, contractual interest",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 513034
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -830475
            },
            {
                "label": "Net unrealized loss on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": -847958
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 8978
            },
            {
                "label": "Net loss before share in net loss of Geneos",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -53967744
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -54402131
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -54402131
            },
            {
                "label": "Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.27
            },
            {
                "label": "Basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 202414445
            },
            {
                "label": "Foreign currency translation",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -14419
            },
            {
                "label": "Unrealized gain (loss) on short-term investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 4861
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -54411689
            },
            {
                "label": "Comprehensive loss attributable to non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Comprehensive loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -54411689
            }
        ]
    }
}